SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-006492
Filing Date
2023-01-25
Accepted
2023-01-25 14:07:13
Documents
14
Period of Report
2023-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm234393d1_8k.htm   iXBRL 8-K 27956
2 EXHIBIT 99.1 tm234393d1_ex99-1.htm EX-99.1 30065
6 GRAPHIC tm234393d1_ex99-1img01.jpg GRAPHIC 3599
  Complete submission text file 0001104659-23-006492.txt   246192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fencf-20230125.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20230125_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20230125_pre.xml EX-101.PRE 22594
8 EXTRACTED XBRL INSTANCE DOCUMENT tm234393d1_8k_htm.xml XML 3617
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 23551995
SIC: 2836 Biological Products, (No Diagnostic Substances)